Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Overall investment in the US facility is estimated around US$50 million
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
We have big plans across our B2C and B2B businesses in India and abroad
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
Subscribe To Our Newsletter & Stay Updated